Early monitoring of ribavirin serum concentration is not useful to optimize hepatitis C virus treatment in HIV-coinfected patients.
about
A pharmacological profile of ribavirin and monitoring of its plasma concentration in chronic hepatitis C infectionRibavirin Concentrations Do Not Predict Sustained Virological Response in HIV/HCV-Coinfected Patients Treated with Ribavirin and Pegylated Interferon in the Swiss HIV Cohort StudyLower ribavirin biodisponibility in patients with HIV-HCV coinfection in comparison with HCV monoinfected patients.Telaprevir and ribavirin interaction: higher ribavirin levels are not only due to renal dysfunction during triple therapy.
P2860
Early monitoring of ribavirin serum concentration is not useful to optimize hepatitis C virus treatment in HIV-coinfected patients.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Early monitoring of ribavirin ...... nt in HIV-coinfected patients.
@en
Early monitoring of ribavirin ...... nt in HIV-coinfected patients.
@nl
type
label
Early monitoring of ribavirin ...... nt in HIV-coinfected patients.
@en
Early monitoring of ribavirin ...... nt in HIV-coinfected patients.
@nl
prefLabel
Early monitoring of ribavirin ...... nt in HIV-coinfected patients.
@en
Early monitoring of ribavirin ...... nt in HIV-coinfected patients.
@nl
P2093
P50
P1433
P1476
Early monitoring of ribavirin ...... ent in HIV-coinfected patients
@en
P2093
Albert Pahissa
Juan I Esteban
Leonor Pou
Manuel Crespo
María Feijoo
Rosa Lopez
Sara Villar del Saz
Silvia Sauleda
P304
P577
2007-01-01T00:00:00Z